Chien-Shing Chen Selected Research

Thrombocytopenia (Thrombopenia)

9/2014	Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma.
3/2010	Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chien-Shing Chen Research Topics

Disease

29	Neoplasms (Cancer) 04/2022 - 10/2006
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 01/2007
4	Multiple Myeloma 06/2015 - 03/2010
4	Leukemia 04/2012 - 01/2007
3	Prostatic Neoplasms (Prostate Cancer) 04/2017 - 11/2006
3	Squamous Cell Carcinoma of Head and Neck 07/2014 - 06/2013
3	Neoplasm Metastasis (Metastasis) 06/2012 - 05/2011
2	Lymphoma (Lymphomas) 02/2021 - 09/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2021 - 09/2003
2	Pneumonia (Pneumonitis) 01/2020 - 09/2003
2	Fatigue 06/2015 - 10/2009
2	Thrombocytopenia (Thrombopenia) 09/2014 - 03/2010
2	Breast Neoplasms (Breast Cancer) 06/2012 - 11/2007
2	Hepatocellular Carcinoma (Hepatoma) 07/2009 - 12/2008
2	Systemic Scleroderma (Systemic Sclerosis) 08/2007 - 09/2003
2	Acute Promyelocytic Leukemia 08/2007 - 10/2006
1	Human Influenza (Influenza) 01/2020
1	Cytokine Release Syndrome 01/2020
1	COVID-19 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Infections 01/2020
1	Tuberculosis (Tuberculoses) 01/2019
1	Fever (Fevers) 03/2018
1	Anemia 03/2018
1	Cutis Laxa 03/2018
1	Exanthema (Rash) 03/2018
1	Polyneuropathies (Polyneuropathy) 03/2018
1	Amyloidosis 03/2018
1	Synovial Sarcoma (Synovioma) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Hypercalcemia (Milk Alkali Syndrome) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2014
1	Lymphopenia (Lymphocytopenia) 09/2014
1	Neutropenia 09/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2014
1	Carcinoma (Carcinomatosis) 07/2014
1	Hypoxia (Hypoxemia) 01/2014
1	Vitamin D Deficiency 01/2014

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 04/2022 - 11/2006
8	Proteins (Proteins, Gene)FDA Link 01/2015 - 10/2006
6	linifanibIBA 07/2014 - 07/2008
5	GenisteinIBA 01/2015 - 01/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 12/2008
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2014 - 07/2009
3	Vitamin D FDA LinkGeneric 01/2020 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2009
3	Bortezomib (Velcade)FDA Link 09/2014 - 07/2011
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2014 - 07/2009
3	AntigensIBA 12/2011 - 11/2006
3	Phosphotransferases (Kinase)IBA 07/2009 - 11/2006
2	Oncogene Proteins (Oncogene Protein)IBA 04/2017 - 06/2012
2	CollagenIBA 10/2015 - 09/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2014 - 11/2008
2	Platelet-Derived Growth FactorIBA 06/2013 - 07/2009
2	ErbB Receptors (EGF Receptor)IBA 06/2012 - 11/2007
2	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 01/2011
2	Tyrosine Kinase InhibitorsIBA 07/2009 - 12/2008
2	Co-Repressor ProteinsIBA 08/2007 - 10/2006
1	CytokinesIBA 04/2022
1	fms-Like Tyrosine Kinase 3IBA 04/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	PrionsIBA 01/2019
1	GelsolinIBA 03/2018
1	lens epithelium-derived growth factorIBA 04/2017
1	Docetaxel (Taxotere)FDA Link 04/2017
1	Taxoids (Taxanes)IBA 04/2017
1	taxaneIBA 04/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	sepantroniumIBA 09/2015
1	Modafinil (Provigil)FDA Link 06/2015
1	Rituximab (Mabthera)FDA Link 09/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2014
1	Prednisone (Sone)FDA LinkGeneric 09/2014
1	Vincristine (Oncovin)FDA LinkGeneric 09/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2014
1	veliparibIBA 07/2014
1	SteroidsIBA 01/2014
1	Angiogenesis InhibitorsIBA 01/2014
1	LipidsIBA 01/2014
1	Heme (Haem)IBA 01/2014
1	IronIBA 01/2014

Therapy/Procedure

11	Therapeutics 10/2015 - 08/2007
5	Drug Therapy (Chemotherapy) 04/2017 - 03/2010
3	Immunotherapy 06/2022 - 12/2011
3	Hematopoietic Stem Cell Transplantation 02/2021 - 09/2003
2	Complementary Therapies (Alternative Medicine) 11/2013 - 09/2012
2	Biological Therapy 04/2012 - 02/2012
1	Organ Transplantation 02/2021
1	Immunomodulation 01/2020
1	Castration 04/2017
1	Radiotherapy 01/2014